Cidara Therapeutics, Inc. (CDTX): Price and Financial Metrics

Cidara Therapeutics, Inc. (CDTX)

Today's Latest Price: $3.19 USD

0.21 (7.05%)

Updated Oct 22 4:00pm

Add CDTX to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 384 in Biotech

See all "A" rated Strong Buy stocks

CDTX Stock Summary

  • Of note is the ratio of Cidara Therapeutics Inc's sales and general administrative expense to its total operating expenses; merely 12.16% of US stocks have a lower such ratio.
  • The ratio of debt to operating expenses for Cidara Therapeutics Inc is higher than it is for about merely 14.87% of US stocks.
  • Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for CDTX comes in at -37.07% -- higher than that of only 11.57% of stocks in our set.
  • If you're looking for stocks that are quantitatively similar to Cidara Therapeutics Inc, a group of peers worth examining would be SYBX, PIRS, NXTC, KALV, and XENE.
  • CDTX's SEC filings can be seen here. And to visit Cidara Therapeutics Inc's official web site, go to

CDTX Stock Price Chart Interactive Chart >

Price chart for CDTX

CDTX Price/Volume Stats

Current price $3.19 52-week high $4.45
Prev. close $2.98 52-week low $1.30
Day low $2.96 Volume 136,500
Day high $3.27 Avg. volume 287,162
50-day MA $3.20 Dividend yield N/A
200-day MA $3.23 Market Cap 137.04M

Cidara Therapeutics, Inc. (CDTX) Company Bio

Cidara Therapeutics, Inc. focuses on the discovery, development, and commercialization of novel anti-infectives for the treatment of diseases. The company was formerly known as K2 Therapeutics, Inc. and changed its name to Cidara Therapeutics, Inc. in June 2014. The company was founded in 2012 and is based in San Diego, California.

CDTX Latest News Stream

Event/Time News Detail
Loading, please wait...

CDTX Latest Social Stream

Loading social stream, please wait...

View Full CDTX Social Stream

Latest CDTX News From Around the Web

Below are the latest news stories about Cidara Therapeutics Inc that investors may wish to consider to help them evaluate CDTX as an investment opportunity.

Cidara Therapeutics EPS misses by $0.14, misses on revenue

Cidara Therapeutics (CDTX): Q2 GAAP EPS of -$0.45 misses by $0.14.Revenue of $3.4M misses by $0.83M.Cash and equivalents and restricted cash totaled $64.1M as of June 30, 2020 vs. $60.3M as of December 31, 2019."We are pleased to have dosed the first patient in our Phase 3 ReSPECT trial, which is evaluating rezafungin for...

Seeking Alpha | August 13, 2020

What Is The Ownership Structure Like For Cidara Therapeutics, Inc. (NASDAQ:CDTX)?

Every investor in Cidara Therapeutics, Inc. (NASDAQ:CDTX) should be aware of the most powerful shareholder groups...

Yahoo | July 19, 2020

Cidara Therapeutics to Participate in B. Riley Virtual Summer Series Panel on Antiviral Therapeutics

SAN DIEGO, July 17, 2020 -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting therapeutics to transform the standard of care for patients.

Yahoo | July 17, 2020

Here is What Hedge Funds Think About Cidara Therapeutics Inc (CDTX)

Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and successful investors' positions as of the end of the first quarter. You can find articles about an individual hedge fund's trades on numerous financial […]

Yahoo | July 6, 2020

Cidara Therapeutics Added to Russell 3000® Index

Cidara Therapeutics, Inc. (CDTX), a biotechnology company developing long-acting therapeutics to transform the standard of care for patients facing serious fungal or viral infections, today announced that it has been added to the Russell 3000® Index at the conclusion of the Russell indexes annual reconstitution, effective upon the U.S. market open today, June 29, 2020. Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. Russell indexes are part of FTSE Russell, a leading global index provider.

Yahoo | June 29, 2020

Read More 'CDTX' Stories Here

CDTX Price Returns

1-mo 9.25%
3-mo -17.14%
6-mo 15.58%
1-year 72.43%
3-year -59.36%
5-year -78.27%
YTD -16.93%
2019 63.40%
2018 -65.44%
2017 -34.62%
2016 -39.39%
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8162 seconds.